An Open Access Database of Licensed Cancer Drugs

A global, comprehensive and open access listing of approved anticancer drugs does not currently exist. Partial information is available from multiple sources, including regulatory authorities, national formularies and scientific agencies. Many such data sources include drugs used in oncology for sup...

Full description

Bibliographic Details
Main Authors: Pan Pantziarka, Rica Capistrano I, Arno De Potter, Liese Vandeborne, Gauthier Bouche
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.627574/full
id doaj-86a2ecc5b4d547199735cd3630fa58de
record_format Article
spelling doaj-86a2ecc5b4d547199735cd3630fa58de2021-03-11T08:59:03ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122021-03-011210.3389/fphar.2021.627574627574An Open Access Database of Licensed Cancer DrugsPan Pantziarka0Pan Pantziarka1Rica Capistrano I2Arno De Potter3Liese Vandeborne4Gauthier Bouche5The Anticancer Fund, Brussels, BelgiumThe George Pantziarka TP53 Trust, London, United KingdomThe Anticancer Fund, Brussels, BelgiumFaculty of Medicine, University of Leuven, Leuven, BelgiumThe Anticancer Fund, Brussels, BelgiumThe Anticancer Fund, Brussels, BelgiumA global, comprehensive and open access listing of approved anticancer drugs does not currently exist. Partial information is available from multiple sources, including regulatory authorities, national formularies and scientific agencies. Many such data sources include drugs used in oncology for supportive care, diagnostic or other non-antineoplastic uses. We describe a methodology to combine and cleanse relevant data from multiple sources to produce an open access database of drugs licensed specifically for therapeutic antineoplastic purposes. The resulting list is provided as an open access database, (http://www.redo-project.org/cancer-drugs-db/), so that it may be used by researchers as input for further research projects, for example literature-based text mining for drug repurposing.https://www.frontiersin.org/articles/10.3389/fphar.2021.627574/fulldrug repurposingdrug licensingantineoplastic drugslicensed drugsdatabaselist of cancer drugs
collection DOAJ
language English
format Article
sources DOAJ
author Pan Pantziarka
Pan Pantziarka
Rica Capistrano I
Arno De Potter
Liese Vandeborne
Gauthier Bouche
spellingShingle Pan Pantziarka
Pan Pantziarka
Rica Capistrano I
Arno De Potter
Liese Vandeborne
Gauthier Bouche
An Open Access Database of Licensed Cancer Drugs
Frontiers in Pharmacology
drug repurposing
drug licensing
antineoplastic drugs
licensed drugs
database
list of cancer drugs
author_facet Pan Pantziarka
Pan Pantziarka
Rica Capistrano I
Arno De Potter
Liese Vandeborne
Gauthier Bouche
author_sort Pan Pantziarka
title An Open Access Database of Licensed Cancer Drugs
title_short An Open Access Database of Licensed Cancer Drugs
title_full An Open Access Database of Licensed Cancer Drugs
title_fullStr An Open Access Database of Licensed Cancer Drugs
title_full_unstemmed An Open Access Database of Licensed Cancer Drugs
title_sort open access database of licensed cancer drugs
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2021-03-01
description A global, comprehensive and open access listing of approved anticancer drugs does not currently exist. Partial information is available from multiple sources, including regulatory authorities, national formularies and scientific agencies. Many such data sources include drugs used in oncology for supportive care, diagnostic or other non-antineoplastic uses. We describe a methodology to combine and cleanse relevant data from multiple sources to produce an open access database of drugs licensed specifically for therapeutic antineoplastic purposes. The resulting list is provided as an open access database, (http://www.redo-project.org/cancer-drugs-db/), so that it may be used by researchers as input for further research projects, for example literature-based text mining for drug repurposing.
topic drug repurposing
drug licensing
antineoplastic drugs
licensed drugs
database
list of cancer drugs
url https://www.frontiersin.org/articles/10.3389/fphar.2021.627574/full
work_keys_str_mv AT panpantziarka anopenaccessdatabaseoflicensedcancerdrugs
AT panpantziarka anopenaccessdatabaseoflicensedcancerdrugs
AT ricacapistranoi anopenaccessdatabaseoflicensedcancerdrugs
AT arnodepotter anopenaccessdatabaseoflicensedcancerdrugs
AT liesevandeborne anopenaccessdatabaseoflicensedcancerdrugs
AT gauthierbouche anopenaccessdatabaseoflicensedcancerdrugs
AT panpantziarka openaccessdatabaseoflicensedcancerdrugs
AT panpantziarka openaccessdatabaseoflicensedcancerdrugs
AT ricacapistranoi openaccessdatabaseoflicensedcancerdrugs
AT arnodepotter openaccessdatabaseoflicensedcancerdrugs
AT liesevandeborne openaccessdatabaseoflicensedcancerdrugs
AT gauthierbouche openaccessdatabaseoflicensedcancerdrugs
_version_ 1724225825371324416